Open AccessA case of BNT162b2 COVID ‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
Author(s) -
Otsuka Kaishi,
Matsuo Takashi,
Ishimatsu Takashi,
Fukae Atsuki,
Hamamoto Takuro,
Oku Koji,
Ito Masahiro
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6161
Subject(s) - medicine , fulminant , myocarditis , covid-19 , vaccination , pediatrics , disease , virology , outbreak , infectious disease (medical specialty)
Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the second dose of BNT162b2 COVID‐19 vaccine. Steroid pulse therapy was effective.